MedTrace Logo

Secondary Cancer Risk After Radiation Therapy for Rectal Cancer

NCT02572362 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2016-12-13

No results posted yet for this study

Summary

Retrospective study comparing dose distribution of 3D conformal radiotherapy (3DCRT) and volumetric-modulated arc therapy (VMAT) to estimate secondary cancer risk for patients having had radiation therapy for rectal cancer. Twenty-five patients are included in this study. Planning CT scans are used for comparison of dose distribution and calculation of second cancer risk.

Conditions

  • Neoplasms, Second Primary

Interventions

OTHER

No intervention in this retrospective study

No Intervention in this retrospective Analysis. All patients included did receive Radiation therapy Independent of this study

Sponsors & Collaborators

  • Klinik Hirslanden, Zurich

    collaborator OTHER

  • Kantonsspital Graubuenden

    lead OTHER

Principal Investigators

  • Daniel R Zwahlen, MD, MBA · Kantonsspital Graubuenden

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02572362 on ClinicalTrials.gov